Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥1,686 JPY
Change Today +11.00 / 0.66%
Volume 113.1K
As of 2:00 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

taiko pharmaceutical co ltd (4574) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/1/14 - ¥2,532
52 Week Low
09/2/15 - ¥1,660
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TAIKO PHARMACEUTICAL CO LTD (4574)

Related News

No related news articles were found.

taiko pharmaceutical co ltd (4574) Related Businessweek News

No Related Businessweek News Found

taiko pharmaceutical co ltd (4574) Details

Taiko Pharmaceutical Co., Ltd. manufactures, procures, and sells non-prescription (OTC) drugs in Japan, Mainland China, Hong Kong, and Taiwan. It offers gastrointestinal drugs under the Seirogan, Seirogan Toi-A, and Pishut brands for the treatment of loose stools, diarrhea, food poisoning, water poisoning, vomiting, and related conditions; and designated quasi drugs comprising Trumpet Intestinal Regulator BF, as well as sells Hiya Kiogan, a prediatric drug. The company also manufactures and sells sanitation control products, such as Cleverin and WE'LL SHIELD; and sells LISPASS Cleverin generator, a machine which emits low concentrations of chlorine dioxide gas. In addition, it supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. Further, the company provides bath additives and pyroligneous acids for horticultural use. Taiko Pharmaceutical Co., Ltd. was founded in 1946 and is headquartered in Osaka, Japan.

205 Employees
Last Reported Date: 06/26/15
Founded in 1946

taiko pharmaceutical co ltd (4574) Top Compensated Officers

Chief Executive Officer, President and Repres...
Total Annual Compensation: ¥116.4M
Compensation as of Fiscal Year 2014.

taiko pharmaceutical co ltd (4574) Key Developments

Taiko Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2016; Announces Consolidated Earnings Results for the First Quarter Ended June 2015; Provides Consolidated Earnings Guidance for Year Ending March 31, 2016

Taiko Pharmaceutical Co., Ltd. provided dividend guidance for the year ending March 31, 2016. For the period, the company expects to pay year-end dividend of ¥15.00 per share against ¥25.00 per share a year ago. Total dividend is expected to be ¥15.00 per share against ¥25.00 per share a year ago. The company announced consolidated earnings results for the first quarter ended June 2015. For the quarter, the company reported net sales of ¥1,429 million against ¥1,453 million a year ago. Operating income was ¥150 million against ¥414 million a year ago. Ordinary income was ¥170 million against ¥410 million a year ago. Profit attributable to owners of parent was $50 million or ¥3.86 per diluted share against ¥271 million ¥20.75 per diluted share a year ago. The company provided consolidated earnings guidance for year ending March 31, 2016. The company expects net sales of ¥9,200 million, operating income of ¥1,550 million, ordinary income of ¥1,450 million and profit attributable to owners of parent of ¥1,000 million or ¥78.24 per share.

Taiko Pharmaceutical Co., Ltd. to Report Q1, 2016 Results on Aug 12, 2015

Taiko Pharmaceutical Co., Ltd. announced that they will report Q1, 2016 results on Aug 12, 2015

Taiko Pharmaceutical Co., Ltd., Annual General Meeting, Jun 26, 2015

Taiko Pharmaceutical Co., Ltd., Annual General Meeting, Jun 26, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4574:JP ¥1,686.00 JPY +11.00

4574 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4574.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4574 Industry Range
Price/Earnings 14.8x
Price/Sales 2.5x
Price/Book 1.8x
Price/Cash Flow 15.3x
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAIKO PHARMACEUTICAL CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at